Welcome to our dedicated page for Equinix SEC filings (Ticker: EQIX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Equinix, Inc. (Nasdaq: EQIX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including annual and quarterly reports, current reports on Form 8-K and registered debt offerings. As a real estate investment trust focused on digital infrastructure and data centers, Equinix uses SEC filings to report its financial performance, capital structure, governance changes and material events that may be relevant to EQIX shareholders and bondholders.
Recent Form 8-K filings describe several key developments. Equinix has reported the issuance of senior notes by indirect, wholly owned subsidiaries, fully and unconditionally guaranteed by Equinix, Inc. These filings detail principal amounts, interest rates, maturity dates, redemption provisions, change-of-control protections and restrictive covenants related to liens, certain asset sales, mergers, consolidations and sale-leaseback transactions. Investors interested in Equinix’s leverage profile and debt maturity schedule can review these documents for precise terms.
Other 8-K filings cover quarterly financial results, including revenue, operating income, adjusted EBITDA and adjusted funds from operations (AFFO), along with reconciliations of non-GAAP measures to GAAP metrics. Equinix also uses 8-Ks to furnish analyst day presentations that outline long-term outlooks for revenue growth, margin expansion, AFFO per share and dividends, providing additional context for evaluating EQIX stock.
Governance and legal matters appear in the filings as well. Equinix has filed 8-Ks regarding the election of independent directors, changes in board committee assignments and standard compensation for non-employee directors. The company has also disclosed the status of regulatory inquiries related to a short seller report, including correspondence from the SEC indicating that its investigation was concluded without an enforcement recommendation and the company’s expectation of no further related action from the U.S. Attorney’s Office for the Northern District of California.
On Stock Titan, these filings are complemented by AI-powered summaries that help explain complex debt indentures, non-GAAP reconciliations and legal disclosures in plain language. Users can quickly see what each 10-K, 10-Q, 8-K or debt prospectus means for Equinix’s business, capital structure and risk profile, while still having direct access to the full text filed with the SEC’s EDGAR system.
Form 144 notice for Equinix, Inc. (EQIX): This filing reports a proposed sale of 59 shares of Equinix common stock, with an aggregate market value of $44,965.71. The shares were acquired as Restricted Stock Units (RSUs) on 09/02/2025 and show the same date for payment. The sale is expected to occur on or about 09/03/2025 through Morgan Stanley Smith Barney LLC on the NASDAQ. The filing lists 97,863,986 shares outstanding for the class. No other sales in the past three months are reported. The filer certifies they are not aware of undisclosed material adverse information.
Equinix (EQIX) filed a Form 144 reporting a proposed sale of 562 common shares acquired as restricted stock units on 09/02/2025. The filing states the securities will be sold through Morgan Stanley Smith Barney LLC on or about 09/03/2025 with an aggregate market value of $427,936.37. The filing notes there were no securities sold in the past three months by the same person and identifies the class, acquisition date, and broker. The filer certifies they are not aware of undisclosed material adverse information about the issuer.
Christopher B. Paisley, an Equinix, Inc. (EQIX) director, reported a sale of 75 shares of common stock on 08/18/2025 at a reported price of $781.50 per share. Following the transaction he is reported to beneficially own 17,832 shares through indirect holdings including the Paisley Family Trust and trusts for family members. The filing is reported on Form 4 and the sale is disclosed as made pursuant to a 10b5-1 trading plan, per the filer’s explanation.
The Form 4 is signed by a power of attorney on behalf of Mr. Paisley and contains no derivative transactions or other material amendments. The report presents a routine insider sale under a pre-established plan and discloses the post-transaction indirect ownership stake.
Equinix, Inc. (EQIX) Form 144 summary: A holder filed a notice to sell 75 shares of Equinix common stock through Fidelity Brokerage Services LLC with an approximate aggregate market value of $58,612.50. The filing lists the total shares outstanding as 97,863,986 and names NASDAQ as the exchange for an approximate sale date of 08/18/2025. The shares were acquired on 05/25/2023 through restricted stock vesting from the issuer and the payment for those shares is recorded as compensation. The filer reports no securities sold in the past three months and attests to having no undisclosed material information. This notice documents a planned sale by a person who received shares as compensation.
Li Yanbing, a director of Equinix, Inc. (EQIX), was granted 255 restricted stock units (RSUs) on 08/12/2025. The RSUs carry no purchase price and are reported as 255 shares of common stock beneficially owned following the grant. The award vests on the earlier of May 21, 2026 or the date of the company’s next annual stockholder meeting if the reporting person does not stand for re-election, provided the reporting person remains in continuous service through vesting. The RSUs expire if the reporting person’s service terminates. The Form 4 was signed by a power of attorney on 08/14/2025.
Li Yanbing, identified as a Director of Equinix, Inc. (EQIX), filed an Initial Statement on Form 3 covering an event dated 08/12/2025. The filing reports that the reporting person does not beneficially own any securities of the issuer. The Form 3 was submitted on behalf of the reporting person and signed by Samantha Lagocki, POA on 08/14/2025. This document is a standard Section 16(a) disclosure establishing initial insider reporting and shows no direct or indirect ownership positions disclosed on the form.
Equinix, Inc. reported that it has elected Dr. Yanbing Li as an independent director to its Board of Directors, effective August 12, 2025. With her election, the Board now consists of nine members. Dr. Li will serve on the Board’s Talent, Culture and Compensation Committee. The company states that her election was not made pursuant to any arrangement or understanding with a third party, and that she is not involved in any transactions requiring disclosure as related-party transactions. As a non-employee director, she will receive Equinix’s standard compensation for non-employee members of the Board.
Equinix (EQIX) filed an 8-K/A to amend the 8-K furnished on 30 Jul 2025. The sole purpose is to replace Exhibit 99.1 with a corrected Q2-25 earnings press release. The company states that three cash-flow line items—“Maturity of short-term investments,” “Business acquisitions, net of cash acquired,” and “Proceeds from mortgage and loans payable”—plus the related subtotals and totals in the Condensed Consolidated Statements of Cash Flows were inadvertently misstated in the original release. No other sections of the prior report are changed.
The corrected release (now re-attached as Exhibit 99.1) continues to be treated as furnished, not filed, under Item 2.02, and therefore does not automatically integrate into other SEC filings unless specifically incorporated by reference. Management also reiterates that non-GAAP metrics are included, with reconciliations provided within the exhibit.
Key takeaways for investors:
- No revision to income statement, balance sheet or guidance was disclosed—only select cash-flow presentation lines.
- The amendment suggests an internal review caught the errors within a day, limiting potential market impact.
- While transparency in issuing an immediate correction is positive, repeat data accuracy lapses could raise internal-control questions if they persist.